These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29191483)

  • 21. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
    Bally L; Thabit H; Hovorka R
    Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
    [No Abstract]   [Full Text] [Related]  

  • 22. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
    Wang Y; Zhang J; Zeng F; Wang N; Chen X; Zhang B; Zhao D; Yang W; Cobelli C
    Diabetes Technol Ther; 2017 Jan; 19(1):41-48. PubMed ID: 28060528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent approaches in insulin delivery.
    Trehan A; Ali A
    Drug Dev Ind Pharm; 1998 Jul; 24(7):589-97. PubMed ID: 9876502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting homeostasis in drug delivery using bioresponsive hydrogel microforms.
    Wilson AN; Guiseppi-Elie A
    Int J Pharm; 2014 Jan; 461(1-2):214-22. PubMed ID: 24333901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
    Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
    Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug delivery system for diabetes].
    Yamasaki Y
    Nihon Rinsho; 1998 Mar; 56(3):748-51. PubMed ID: 9549368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioresponsive drug delivery systems for the treatment of inflammatory diseases.
    Dou Y; Li C; Li L; Guo J; Zhang J
    J Control Release; 2020 Nov; 327():641-666. PubMed ID: 32911014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment.
    Li C; Wan L; Luo J; Jiang M; Wang K
    Int J Nanomedicine; 2021; 16():1261-1280. PubMed ID: 33628020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progress in design and preparation of glucose-responsive insulin delivery systems.
    Shen D; Yu H; Wang L; Khan A; Haq F; Chen X; Huang Q; Teng L
    J Control Release; 2020 May; 321():236-258. PubMed ID: 32061789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloprotease triggered bioresponsive drug delivery systems - Design, synthesis and application.
    Nultsch K; Germershaus O
    Eur J Pharm Biopharm; 2018 Oct; 131():189-202. PubMed ID: 30145219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment.
    Yu J; Zhang Y; Bomba H; Gu Z
    Bioeng Transl Med; 2016 Sep; 1(3):323-337. PubMed ID: 29147685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances of bioresponsive polymeric nanomedicine for cancer therapy.
    Hong T; Shen X; Syeda MZ; Zhang Y; Sheng H; Zhou Y; Xu J; Zhu C; Li H; Gu Z; Tang L
    Nano Res; 2023; 16(2):2660-2671. PubMed ID: 36405982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in glucose-responsive insulin delivery systems: novel hydrogels and future applications.
    Mohanty AR; Ravikumar A; Peppas NA
    Regen Biomater; 2022; 9():rbac056. PubMed ID: 36072265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered bioresponsive nanotherapeutics: recent advances in the treatment of atherosclerosis and ischemic-related disease.
    Rumanti AP; Maruf A; Liu H; Ge S; Lei D; Wang G
    J Mater Chem B; 2021 Jun; 9(24):4804-4825. PubMed ID: 34085084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mathematical analysis of rebound in a target-mediated drug disposition model: II. With feedback.
    Aston PJ; Derks G; Agoram BM; van der Graaf PH
    J Math Biol; 2017 Jul; 75(1):33-84. PubMed ID: 27832321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restoring immune balance in type 1 diabetes.
    Herold KC
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):261-3. PubMed ID: 24622404
    [No Abstract]   [Full Text] [Related]  

  • 40. Closed-loop bioelectronic medicine for diabetes management.
    Güemes Gonzalez A; Etienne-Cummings R; Georgiou P
    Bioelectron Med; 2020; 6():11. PubMed ID: 32467827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.